DouglasG.RogersMD

PubMed

• Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances.
  Akhtar, S., Akhtar, S., Patel, L., Patel, L., Bakhach, M., Bakhach, M., Haider, A., Haider, A., Gonzalez-Martinez, J., Gonzalez-Martinez, J., Rogers, D., Rogers, D., T...> ;Clinical pediatrics. 2015 Nov 20
• 5 citations
  Growth hormone treatment in a patient with Hurler-Scheie syndrome.
  Douglas Rogers, Nat Nasomyont> ;Journal of Pediatric Endocrinology & Metabolism. 2014 Sep 20
• 4 citations
  Response to growth hormone treatment in a patient with 18p-syndrome
  Douglas Rogers, Ramachandra S. Aswini> ;Journal of Pediatric Endocrinology & Metabolism. 2012 Oct 1
• 5 citations
  Herpesvirus Infections in Rock Hyraxes (Procavia Capensis)
  Judith A. Galeota, Julia E. Napier, Douglas L. Armstrong, Jean-Jack M Riethoven, Douglas G. Rogers> ;Journal of Veterinary Diagnostic Investigation. 2009 Jul 1
• 3 citations
  Metastatic angioinvasive lymphoma (lymphomatoid granulomatosis) in a cat.
  Douglas G. Rogers, Valerie A. Aliano> ;Journal of Veterinary Diagnostic Investigation. 2009 May 1
• 5 citations
  Final diagnosis: transient pseudohypoaldosteronism (TPH) caused by UTI without concordant obstructive uropathy.
  Douglas Rogers> ;Clinical Pediatrics. 2008 May 1
• 20 citations
  Effects of Moraxella (Branhamella) ovis culture filtrates on bovine erythrocytes, peripheral mononuclear cells, and corneal epithelial cells.
  Henry E. Cerny, Douglas G. Rogers, J. T. Gray, David R. Smith, Susanne Hinkley> ;Journal of Clinical Microbiology. 2006 Mar 1
• 32 citations
  Serologic survey of select infectious diseases in coyotes and raccoons in Nebraska.
  Richard Bischof, Douglas G. Rogers> ;Journal of Wildlife Diseases. 2005 Oct 1
• 18 citations
  West Nile virus infection in reindeer (Rangifer tarandus).
  Mitchell V. Palmer, William C. Stoffregen, Douglas G. Rogers, Amir N. Hamir, Juergen A. Richt, Douglas D. Pedersen, W. Ray Waters> ;Journal of Veterinary Diagnostic Investigation. 2004 May 1
• 104 citations
  Accuracy and Precision of Low-Dose Insulin Administration Using Syringes, Pen Injectors, and a Pump
  Katherine Keith, David Nicholson, Douglas Rogers> ;Clinical Pediatrics. 2004 Jan 1
• 1 citations
  Parelaphostrongylus tenuis in captive pronghorn antelope (Antilocapra americana) in Nebraska.
  Heather A. Simmons, David J. Steffen, Douglas L. Armstrong, Douglas G. Rogers> ;Journal of Wildlife Diseases. 2002 Oct 1
• 15 citations
  Genital Tract Tumors in Proteus Syndrome: Report of a Case of Bilateral Paraovarian Endometrioid Cystic Tumors of Borderline Malignancy and Review of the Literature
  Rajeeva R. Raju, William R. Hart, David K Magnuson, Janet R Reid, Douglas G Rogers> ;Modern Pathology. 2002 Feb 1
• 18 citations
  Septicemia Associated with Stenotrophomonas Maltophilia in a West African Dwarf Crocodile (Osteolaemus Tetraspis Subsp. Tetraspis)
  N. Beth Harris, Douglas G. Rogers> ;Journal of Veterinary Diagnostic Investigation. 2001 May 1
• 15 citations
  Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach.
  Nusrat Khan, Angelo A. Licata, Douglas Rogers> ;Clinical Pediatrics. 2001 Apr 1
• 6 citations
  A patient with de Morsier and Duane syndromes
  Blanca I. Aguirre-Aquino, Douglas Rogers, Elias I. Traboulsi> ;Journal of AAPOS. 2000 Aug 1
• 24 citations
  Intestinal Lesions Caused by a Strain of Chlamydia Suis in Weanling Pigs Infected at 21 Days of Age
  Douglas G. Rogers, Arthur A. Andersen> ;Journal of Veterinary Diagnostic Investigation. 2000 May 1
• 1 citations
  Morbid obesity in a young child.
  Douglas Rogers> ;Clinical Pediatrics. 2000 Mar 1
• 28 citations
  Conjunctivitis caused by a swine Chlamydia trachomatis-like organism in gnotobiotic pigs.
  Douglas G. Rogers, Arthur A. Andersen> ;Journal of Veterinary Diagnostic Investigation. 1999 Jul 1
• 6 citations
  Isolation of Cilia-Associated Respiratory (CAR) Bacillus from Pigs and Calves and Experimental Infection of Gnotobiotic Pigs and Rodents:
  Jerome C. Nietfeld, Barry L. Fickbohm, Douglas G. Rogers, Craig L. Franklin, Lela K. Riley> ;Journal of Veterinary Diagnostic Investigation. 1999 May 1
• 35 citations
  Intestinal Lesions Caused by Two Swine Chlamydial Isolates in Gnotobiotic Pigs
  Douglas G. Rogers, Arthur A. Andersen> ;Journal of Veterinary Diagnostic Investigation. 1996 Oct 1
• 37 citations
  Effects of Heredity, Age, Weight, Puberty, Activity, and Calcium Intake on Bone Mineral Density in Children
  M. Deborah Lonzer, Ruth Imrie, Douglas Rogers, Deborah Worley, Angelo A. Licata, Michelle Secic> ;Clinical Pediatrics. 1996 Apr 1
• 44 citations
  Lung and nasal lesions caused by a swine chlamydial isolate in gnotobiotic pigs
  Douglas G. Rogers, Arthur A. Andersen, Breck D. Hunsaker> ;Journal of Veterinary Diagnostic Investigation. 1996 Jan 1
• 1 citations
  Pancreatic and Islet Replacement Therapy For Insulin-Dependent Diabetes Mellitus
  Ben H. Brouhard, Douglas Rogers> ;Clinical Pediatrics. 1993 May 1
• 23 citations
  Diarrhea Associated with Enterococcus Durans in Calves
  Douglas G. Rogers, David H. Zeman, E. Denis Erickson> ;Journal of Veterinary Diagnostic Investigation. 1992 Oct 1
• 5 citations
  Puberty and Insulin-Dependent Diabetes Mellitus
  Douglas Rogers> ;Clinical Pediatrics. 1992 Mar 1
• Join now to see all

Journal Articles

• Growth hormone treatment in a patient with Hurler-Scheie syndrome  
  Rogers DG, Nasomyont N, J Pediatr Endocrinol Metab, 5/13/2014
• A Simplified Method for Screening Individuals at Risk of Developing Type 1 Diabetes Mellitus: An Assay for Combined Measurement of Three Autoantibodies (GADA, IA-2A an...  
  Siraj ES, Rogers DG, Gupta MK, Reddy SSK, Horm Metab Res, 1/1/2012
• Response to growth hormone treatment in a patient with 18 P-syndrome  
  Rogers DG, Ramachandra SA, J Pediatric Endocrinology and Metabolism, 1/1/2012
• The Application of the Diabetes Prevention Trial Risk Score (DPTRS) for Identifying a Pre-Clinical State of Type 1 Diabetes  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, The TrialNet and Diabetes Prevention Tri..., Diabetes Care, 1/1/2012
• Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High Risk Population-Receiver Operating Characteristic Analysis  
  Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2012
• Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies  
  Yu L, Boulware DC, Beam CA, John C. Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL for the Type 1 Diabete..., Diabetes Care, 1/1/2012
• Fall in C-peptide Over First Two Years from Diagnosis: Evidence of At Least Two Distinct Phases from Composite TrialNet Data  
  Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC, Lachin JM, McGee P, Palmer JP, Pescovitz MD, Krause-Steinrauf H, Skyler JS, Sosenko JM, Type 1 ..., Diabetes, 1/1/2012
• Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP, and the TEDDY, TRIGR, Diabetes Prevention Trial-Type..., Diabetes Care, 1/1/2012
• Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for Repeat Screening Throughout Childhood  
  Vehik K, Haller MJ, Beam CA, Schatz DA, Wherrett DK, Sosenko JM, Krischer J, theDPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• Long Term Outcome of Individuals Treated with Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) Oral Insulin Trial  
  Vehik K, Cuthbertson D, Ruhling H, Schatz DA, Peakman M, Krischer JP, on behalf of the DPT-1 & TrialNet Study Groups (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• The Validation of the Diabetes Prevention Trial-Type 1 RiskScore and the Detection of Pre-Diabetes in the TrialNet Natural History Study  
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, the TrialNet and Diabetes Prevention Tri..., DiabetesCare, 1/1/2011
• A Longitudinal Study of GAD65 and ICA512 Autoantibodies during the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) Participants (Brief Report)  
  Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Cuthbertson D, Yu L, Schatz DA, Orban T, Eisenbarth G, Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Stu..., Diabetes Care, 1/1/2011
• Comparison of Two Insulin Assays for First-Phase Insulin Release in Type 1 Diabetes Prediction and Prevention Studies  
  Mahon JL, Beam CA, Marcovina SM, Boulware DC, Palmer JP, Winter WE, Skyler JS, Krischer JP and the Type 1 Diabetes TrialNet Study Group (Rogers DG-Study Group Member), Clin Chim Acta, 1/1/2011
• Effect of Rituximab on Human In Vivo Antibody Immune Responses  
  Pescovitz M, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum C, Herold KC, Skyler JS, Weinberg A, the Type 1 Diabetes ..., J Allergy Clin Immunol, 1/1/2011
• Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Diabetes  
  Lachin J, Friedenberg-McGee P, Greenbaum CJ, Spain L, Palmer J, Pescovitz MD, Gottlieb P, Skyler J, for the Type 1 Diabetes TrialNet Study Group (Rogers DG-Study Group..., PLOS One, 1/1/2011
• Development of Autoantibodies in the TrialNet Natural History Study (NHS)  
  Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, Skyler JS, Krischer JP for the TrialNet Natural History Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2011
• Increased T Cellular Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes  
  Herold K, Pescovitz M, McGee P, Krause-Steinrauf H, Spain L, Bourcier K, Asare A, Liu Z, Lachin J, Dosch HM, for the Type 1 Diabetes TrialNet Study Group (Rogers DG-St..., J Immunology, 1/1/2011
• Trends of Earlier and Later Responses of C-Peptide to Oral Glucose Challenges with Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants  
  Sosenko JM, Palmer JP, Rafkin LE, Krischer JP, Cuthbertson D, Greenbaum CJ, Eisenbarth GS, Skyler JS, and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2010
• Progression to Diabetes in Relatives of Patients with Type 1 Diabetes: Mechanisms and Mode of Onset  
  Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS, for the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes, 1/1/2010
• Glucose Excursions between States of Glycemia with Progression to Type 1 Diabetes in the Diabetes Prevention Trial Type 1 (DPT-1)  
  Sosenko J, Skyler J, Krischer J, Greenbaum C, Mahon J, Rafkin-Mervis L, Cuthbertson D, Cowie C, Herold K, Eisenbarth G, Palmer J, the Diabetes Prevention Trial-1 Study..., Diabetes, 1/1/2010
• Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes  
  Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer J, Skyler J, Sosenko J, and the Diabetes Prevention Trial-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2010
• Pancreatic Islet Cell Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)  
  Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz DA, Eisenbarth GS, and the DPT-1 Study Group (Rogers DG-Study Group Member), Diabetes Care, 1/1/2009
• Validity and Reproducibility of Measurement of Islet Autoreactivity by T-cell Assays in Subjects with Early Type 1 Diabetes  
  Herold KC, Brooks-Worrell B, Palmer JP, Dosch HM, Peakman M, Gottlieb PA, Reijonen H, Arif S, Spain LM, Thompson C, Lachin JM, and The Type 1 Diabetes TrialNet Researc..., Diabetes, 1/1/2009
• Final diagnosis: transient pseudohypaldosteronism (TPH) caused by UTI without concordant obstructive uropathy  
  Rogers D, Clinical Pediatrics, 1/1/2008
• A Risk Score for Type 1 Diabetes Derived from Autoantibody Positive Participants in The Diabetes Prevention Trial-Type 1  
  Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS, and the Diabetes Prevention Trial-1 Study Group (Rogers DG-Stu..., Diabetes Care, 1/1/2008
• Join now to see all

Books/Book Chapters

• Pediatric Gastrointestinal and Liver Disease 
  Chapter: Eating disorders and obesity. 
  Page 217 - 232Antonson DL, Rogers DG, Madison JKEditors: R Wyllie, JS Hyams.Elsevier, PhiladelphiaEdition 3rd,2006
• Clinical Preventive Medicine 
  Chapter: Prevention of diabetes mellitus. 
  Page 725 - 733Campbell JP, Rogers DGEditors: RS Lang, DD Hensrud.AMA Press, United States of AmericaEdition 2nd,2004
• The Cleveland Clinic Intensive Review of Pediatrics 
  Chapter: Thyroid disease. 
  Page 132 - 136Rogers DGEditors: C Sabella, RJ Cunningham III, DS Moodie.Lippincott Williams & Wilkins, Philadelphia2003
• The Cleveland Clinic Intensive Review of Pediatrics 
  Chapter: Short stature and growth hormone therapy. 
  Page 142 - 147Rogers DGEditors: C Sabella, RJ Cunningham III, DS Moodie.Lippincott Williams & Wilkins, Philadelphia2003
• Essence of Office Pediatrics 
  Chapter: Short stature, management. 
  Rogers DGEditors: JA Stockman III, JA Lohr.W.B. Saunders Company, Philadelphia2001
• The Science and Practice of Pediatric Cardiology 
  Chapter: Endocrinology: Consideration for the pediatric cardiologist. 
  Page 2491 - 2500Rogers DGEditors: A Garson, JT Bricker, DG McNamara.Lea and Febiger, Philadelphia1990
• Join now to see all

Abstracts/Posters

• Efficacy of 3 Day Blinded Continuous Glucose Monitoring System on HbA1c in Children and Adolescents with Type 1 Diabetes Mellitus.
  Rogers D, Klein J, Aswini RS, Worley S, American Association of Clinical Endocrinologist Annual Meeting, 1/1/2011
• Efficacy of 3 Day Blinded Continuous Glucose Monitoring System on HbA1c in Children and Adolescents with Type 1 Diabetes Mellitus.
  Rogers D, Haider A, Klein J, Aswini RS, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2011
• Safety and efficacy results of an 86-week, open-label study of PK-based, once-daily dosing of rhIGF-1 in children with primary IGF-1 deficiency.
  Rogers D, Gonzalez-Mendoza L, Soyka L, Frane J, Bright GM, LWPES ESPE, 1/1/2009
• 15 Year Follow up Analysis of Parental Attitudes Toward Short Stature.
  Feldt M, MacLeish S, Rogers D, Silvers J, Cuttler L, Horm Res; LWPES-ESPE, 1/1/2009
• First-year height velocities with once-daily and twice-daily dosing of rhIGF-1 in two clinical trials of prepubertal dhildren with primary IGF-1 deficiency.
  Midyett LK, Rogers D, Hale D, Rogol A, Frane J, Bright GM, Endocrine Society Annual Meeting, 1/1/2009
• Once-daily rhIGF-1 Treatment in Prepubertal Children with Primary IGFD: First-year Results from a Clinical Trial.
  Rogers D, Soyka L, Woods K, Frane J, Bright JM, Pediatric Academic Societies' Annual Meeting, 1/1/2009
• Screening for celiac and thyroid disease in pediatric patients with Down syndrome.
  Sammon B, Rogers D, Worley S, Tang A, Pediatric Academic Societies' Annual Meeting, 1/1/2008
• Safety and Efficacy of Once-Daily rhIGF-1 Treatment in Prepubertal Children with Primary IGF-1 Deficiency: Results from a Clinical Trial.
  Bright G, Rogers D, Gonzalez Mendoza L, Frane J, ICE, 1/1/2008
• Experience with physiologic replacement dosing with recombinant human IGF-1(rhIGF-1) in pre-pubertal children with primary IGF-1 deficiency (IGFD).
  Moshang T, Rogers D, Frane J, Bright G, Endocrine Society Annual Meeting, 1/1/2007
• Final adult height in patients with constitutional delay of growth and puberty treated with oxandrolone.
  Bedocs LA, Rogers DG, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2006
• Cholesterol/HDL ratio and Non-HDL cholesterol levels in children with type 1 diabetes mellitus: Correlation with glycemic control.
  Rahhal S, Rogers D, Worley S, Pediatric Academic Societies' Annual Meeting, 1/1/2005
• Prevalence of positive celiac disesase antibodies in children attending a pediatric endocrinology clinic.
  Lepejian G, Rogers D, Worley S, Cotman K, Pediatr Res, 1/1/2004
• Prevalence of positive celiac disesase antibodies in children attending a pediatric endocrinology clinic.
  Lepejian G, Rogers D, Worley S, Cotman K, Midwest Society for Pediatric Research, 44th Annual Meeting, 1/1/2003
• Comprehensive CYP21 genotyping for congenital adrenal hyperplasia.
  Vogel NM, Ford A, Rogers D, Witchel S, Dobrowolski S, Naylor E, Midwest Society for Pediatric Research, 43rd Annual Meeting, 1/1/2002
• Endogenous insulin retention by oral insulin in newly diagnosed antibody positive type-1 diabetes.
  Krischer J, Ten S, Marker J, Coutant R, Kukreja A, Zhong CH, Raskin P, Bode B, Vargas A, Rogers D, Schatz D, Deeb L, Marks J, Schwatz S, Malone J, Rappaporte R, Zeidle..., 61st Scientific Sessions, The American Diabetes Association, 1/1/2001
• A simple screening method for individuals at risk of developing type 1 diabetes: Measurement of islet cell auto-antibodies (GADA, IA-2A and IAA) on dried capillary blo...
  Siraj E, Rogers D, Gupta M, Reddy S, Arciaga R, Knipper N, 83rd Annual Meeting of the Endocrine Society, 1/1/2001
• A simple screening test for auto-antibodies associated with the development of type 1 diabetes: Measurement of GADA, IA-2A and IAA from capillary blood collected on fi...
  Siraj E, Rogers D, Gupta M, Switzer C, Knipper N, LWPES/ESPE 6th Joint Meeting, 1/1/2001
• The use of intravenous pamidronate to treat hypercalcemia due to subcutaneous fat necrosis.
  Khan N, Rogers DG, 10th symposium of the Polish Pediatric Endocrine Society, 1/1/2000
• Efficacy of different treatment modalities in children with acanthosis nigricans.
  Appachi M, Noel A, Rogers D, Midwest Society for Pediatric Research, 41st Annual Meeting, 1/1/2000
• Effects of recombinant human growth hormone therapy in pediatric patients with Crohn's disease.
  Laman D, Wyllie R, Rogers D, Balsells F, Sarigol S, Kay M, J Pediatr Gastroenterol Nutr; 13th Annual Meeting of the North American Society for Pediatric Gastroenterology and Nutrition, 1/1/1999
• Effects of recombinant human growth hormone therapy in pediatric patients with Crohn's disease.
  Laman D, Wyllie R, Rogers D, Balsells F, Sarigol S, Kay M, Am J Gastroenterol; American College of Gastroenterology, 1/1/1999
• Oral insulin therapy in newly-diagnosed immune mediated (type I) diabetes. Preliminary analysis of a randomized double blind placebo controlled study.
  Coutant R, Zeidler A, Rappaport R, Schatz D, Schwartz S, Malone J, Raskin P, Rogers D, Bode, B, Crockett S, Marks J, Deeb L, Chalew S, MacLaren N, 58th Scientific Sessions, The American Diabetes Association, 1/1/1998
• Thyroxin therapy in children with primary and secondary hypothyroidism.
  Medina MP, Rogers DG, Maalouf N, Midwest Society for Pediatric Research 39th Annual Meeting, 1/1/1998
• Serum prostate specific antigen and testosterone levels during pubertal development in boys: role for SHBG in regulating the onset of puberty?
  Kim MR, Gupta MK, Travers SH, Rogers DG, Van Lente F, Faiman F, 10th International Congress of Endocrinology, 1/1/1996
• Interactions between puberty and IDDM.
  Rogers DG, Brouhard BH, J Endocrinol Invest; 15th Annual Polish Endocrine Society Meetings, 1/1/1996
• Join now to see all

Lectures

• "Management of DKA." 
  Cleveland, OH - 10/1/2014
• Grand Rounds: "Evaluation and management of growth failure." 
  MetroHealth Medical Center Department of Pediatrics, Cleveland, OH - 9/18/2014
• "Polycystic ovary syndrome." 
  Cleveland Clinic, Cleveland, OH - 4/16/2014
• "Vascular complications of diabetes." 
  Cleveland Clinic, Cleveland, OH - 2/13/2014
• "Evaluation and management of growth failure." 
  Cleveland, OH - 2/7/2014
• Pediatric Grand Rounds: "Hyperlipidemia in Children." 
  Cleveland Clinic Foundation, Cleveland, OH - 2/4/2014
• "Metabolic Syndrome in Children." 
  Hillcrest Hospital, Cleveland, OH - 10/23/2013
• Internal Medicine Grand Rounds: "Insulin pumps and continuous glucose monitors." 
  St. Vincent Charity Medical Center, Cleveland, OH - 4/4/2013
• Pediatric Morbidity and Mortality Grand Rounds: "Disconnecting an insulin pump prior to a procedure." 
  Cleveland Clinic Foundation, Cleveland, OH - 4/2/2013
• "Disorders of puberty." 
  Cleveland, OH - 3/13/2013
• "Hyperlipidemia in Children." 
  Cleveland, OH - 2/15/2013
• "Starting new diabetics on insulin." 
  Cleveland, OH - 8/8/2012
• Adult Endocrine Grand Rounds: "Celiac Disease." 
  Cleveland Clinic, Cleveland, OH - 6/22/2012
• Internal Medicine Grand Rounds: "Metabolic Syndrome." 
  St. Vincent Charity Medical Center, Cleveland, OH - 6/15/2012
• Grand Rounds: "Insulin pumps and continuous glucose monitors." 
  MetroHealth Medical Center Department of Pediatrics, Cleveland, OH - 4/13/2012
• Grand Rounds: "Calcium and Vitamin D Disorders in Children." 
  Cleveland Clinic, Pediatric Institute, Cleveland, OH - 1/24/2012
• "Amenorrhea" 
  10/5/2011
• "Evaluation and management of short stature." 
  Cleveland, OH - 6/17/2011
• Grand Rounds: "Disorders of Puberty." 
  Hillcrest Hospital Department of Pediatrics, Mayfield Heights, OH - 5/6/2011
• "Calcium and Vitamin D Disorders in Children." 
  Beachwood, OH - 4/30/2011
• Grand Rounds: "Diabetic Ketoacidosis in Children." 
  4/6/2011
• "Diabetes in Children." 
  Cleveland, OH - 4/4/2011
• "Puberty disorders." 
  4/1/2011
• Pediatric Grand Rounds: "Celiac Disease." 
  Michigan State University, Kalamazoo Center for Medical Studies - 3/18/2011
• "Celiac Disease." 
  Cleveland, OH - 3/16/2011
• Join now to see all

Other

• Web Chat: "Diabetes in children." 
  Douglas George Rogers, MD
  Cleveland Clinic, Cleveland OH - 6/20/2012
• Diabetes Mellitus Type 2 in Children. 
  Rogers DG, First Consult
  http://www.firstconsult.com/das/pdxmd/body/404608577-54/0?type=med&eid=9-u1.0-_1_mt_1011045&tab=T
  1/1/2012
• NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. 
  Rogers DG (Consensus Panel Member)
  http://www.consensus.nih.gov/2006/MVMDRAFT051706.pdf
  5/15/2006
• "NIH consensus panel: Celiac disease" 
  Rogers DG
  http://consensus.nih.gov/cons/118/118celiacPDF.pdf
  1/1/2004
• "Short Stature." 
  Douglas George Rogers, MD, Family Practice, Audio-Digest, Vol.44, No. 41
  11/4/1996
• "Thyroid disease-How and when to evaluate." 
  Douglas George Rogers, MD, Audio-Digest Foundation, Vol.41, No. 20
  10/24/1995
• "Growth hormone-Use and abuse." 
  Douglas George Rogers, MD, Audio-Digest Foundation, Vol.41, No. 20
  10/24/1995
• Join now to see all